Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger L Albin

Showing results (141-150 of 242) with videos related to

Pageof 25
Sort By:
Journal of Labelled Compounds & Radiopharmaceuticals|November 29, 2013
(-)-[(18) F]Flubatine: evaluation in rhesus monkeys and a report of the first fully automated radiosynthesis validated for clinical useBrian G Hockley, Megan N Stewart, Phillip Sherman, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 21, 2023
Blood-based biomarkers for Alzheimer's disease and cognitive function from mid- to late lifeXin Wang, Kelly M Bakulski, Carrie A Karvonen-Gutierrez, et al.
Aging Brain|July 6, 2023
Regional serotonin terminal density in aging human brain: A [<sup>11</sup>C]DASB PET studyPrabesh Kanel, Robert A Koeppe, Vikas Kotagal, et al.
Movement Disorders Clinical Practice|December 12, 2017
Color discrimination errors associate with axial motor impairments in Parkinson's diseaseNicolaas I Bohnen, Jacob Haugen, Andrew Ridder, et al.
Medrxiv : the Preprint Server for Health Sciences|September 2, 2025
Exposure to Lead and Incidence of Alzheimer Disease and All-Cause Dementia in the United StatesXin Wang, Kelly M Bakulski, Erika Walker, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|January 20, 2006
Positron emission tomography of monoaminergic vesicular binding in aging and Parkinson diseaseNicolaas I Bohnen, Roger L Albin, Robert A Koeppe, et al.
Journal of Integrative Neuroscience|September 30, 2024
Topography of Cholinergic Nerve Terminal Vulnerability and Balance Self-Efficacy in Parkinson's DiseaseJaimie Barr, Robert Vangel, Prabesh Kanel, et al.
Journal of Neuropathology and Experimental Neurology|January 26, 2008
Mortalin: a protein associated with progression of Parkinson disease?Min Shi, Jinghua Jin, Yan Wang, et al.
Scientific Reports|October 6, 2016
COMPASS: A computational model to predict changes in MMSE scores 24-months after initial assessment of Alzheimer's diseaseFan Zhu, Bharat Panwar, Hiroko H Dodge, et al.
Molecular Psychiatry|August 8, 2018
Quantification of brain cholinergic denervation in dementia with Lewy bodies using PET imaging with [<sup>18</sup>F]-FEOBVSiamak Nejad-Davarani, Robert A Koeppe, Roger L Albin, et al.
Pageof 25

Showing results (141-150 of 242) with videos related to

Sort By:
Pageof 25
Journal of Labelled Compounds & Radiopharmaceuticals|November 29, 2013
(-)-[(18) F]Flubatine: evaluation in rhesus monkeys and a report of the first fully automated radiosynthesis validated for clinical useBrian G Hockley, Megan N Stewart, Phillip Sherman, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 21, 2023
Blood-based biomarkers for Alzheimer's disease and cognitive function from mid- to late lifeXin Wang, Kelly M Bakulski, Carrie A Karvonen-Gutierrez, et al.
Aging Brain|July 6, 2023
Regional serotonin terminal density in aging human brain: A [<sup>11</sup>C]DASB PET studyPrabesh Kanel, Robert A Koeppe, Vikas Kotagal, et al.
Movement Disorders Clinical Practice|December 12, 2017
Color discrimination errors associate with axial motor impairments in Parkinson's diseaseNicolaas I Bohnen, Jacob Haugen, Andrew Ridder, et al.
Medrxiv : the Preprint Server for Health Sciences|September 2, 2025
Exposure to Lead and Incidence of Alzheimer Disease and All-Cause Dementia in the United StatesXin Wang, Kelly M Bakulski, Erika Walker, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|January 20, 2006
Positron emission tomography of monoaminergic vesicular binding in aging and Parkinson diseaseNicolaas I Bohnen, Roger L Albin, Robert A Koeppe, et al.
Journal of Integrative Neuroscience|September 30, 2024
Topography of Cholinergic Nerve Terminal Vulnerability and Balance Self-Efficacy in Parkinson's DiseaseJaimie Barr, Robert Vangel, Prabesh Kanel, et al.
Journal of Neuropathology and Experimental Neurology|January 26, 2008
Mortalin: a protein associated with progression of Parkinson disease?Min Shi, Jinghua Jin, Yan Wang, et al.
Scientific Reports|October 6, 2016
COMPASS: A computational model to predict changes in MMSE scores 24-months after initial assessment of Alzheimer's diseaseFan Zhu, Bharat Panwar, Hiroko H Dodge, et al.
Molecular Psychiatry|August 8, 2018
Quantification of brain cholinergic denervation in dementia with Lewy bodies using PET imaging with [<sup>18</sup>F]-FEOBVSiamak Nejad-Davarani, Robert A Koeppe, Roger L Albin, et al.
Pageof 25